282 related articles for article (PubMed ID: 2337105)
1. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
Giacomelli R; Valentini G; Salsano F; Cipriani P; Sambo P; Conforti ML; Fulminis A; De Luca A; Farina G; Candela M; Generini S; De Francisci A; Tirri E; Proietti M; Bombardieri S; Gabrielli A; Tonietti G; Cerinic MM
J Rheumatol; 2002 Apr; 29(4):731-6. PubMed ID: 11950014
[TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
[TBL] [Abstract][Full Text] [Related]
5. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
6. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
[TBL] [Abstract][Full Text] [Related]
7. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis.
Colaci M; Sebastiani M; Giuggioli D; Manfredi A; Spagnolo P; Luppi F; Richeldi L; Ferri C
Scand J Rheumatol; 2010 Mar; 39(2):155-9. PubMed ID: 20059446
[TBL] [Abstract][Full Text] [Related]
10. [Bronchoalveolar lavage findings in the pulmonary impairment related to systemic sclerosis].
Ioanăş M; Ioniţă D; Cerviş L; Bîscă N; Serbănescu A; Nicolau A
Pneumologia; 2002; 51(3):203-5. PubMed ID: 12602092
[TBL] [Abstract][Full Text] [Related]
11. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance.
Wells AU; Hansell DM; Rubens MB; Cullinan P; Haslam PL; Black CM; Du Bois RM
Am J Respir Crit Care Med; 1994 Aug; 150(2):462-8. PubMed ID: 8049830
[TBL] [Abstract][Full Text] [Related]
12. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.
Clements PJ; Goldin JG; Kleerup EC; Furst DE; Elashoff RM; Tashkin DP; Roth MD
Arthritis Rheum; 2004 Jun; 50(6):1909-17. PubMed ID: 15188367
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Abnormalities on High-Resolution Computerized Tomography, Pulmonary Function, and Bronchoalveolar Lavage in Progressive Systemic Sclerosis.
Cakmak G; Selcuk Can T; Gundogdu S; Akman C; Ikitimur H; Musellim B; Ongen G
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):349-354. PubMed ID: 28079847
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary inflammation in systemic sclerosis. An assessment by bronchoalveolar lavage].
Salaffi F; Subiaco S; Carotti M; Blasetti P; Cervini C
Recenti Prog Med; 1994 Oct; 85(10):475-80. PubMed ID: 7809460
[TBL] [Abstract][Full Text] [Related]
15. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis.
Cailes JB; O'Connor C; Pantelidis P; Southcott AM; Fitzgerald MX; Black CM; du Bois RM
Eur Respir J; 1996 May; 9(5):992-9. PubMed ID: 8793462
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
Várai G; Earle L; Jimenez SA; Steiner RM; Varga J
J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
